K243989

Substantially Equivalent

Second Opinion® 3D

Applicant: Pearl, Inc.
Product code: QIH
Advisory panel: Radiology
Date received: 2024-12-26
Decision date: 2025-05-23
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Beverly Hills, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.